1. Home
  2. EVAX vs IMCC Comparison

EVAX vs IMCC Comparison

Compare EVAX & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVAX
  • IMCC
  • Stock Information
  • Founded
  • EVAX 2008
  • IMCC 1980
  • Country
  • EVAX Denmark
  • IMCC Israel
  • Employees
  • EVAX N/A
  • IMCC N/A
  • Industry
  • EVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • IMCC Medicinal Chemicals and Botanical Products
  • Sector
  • EVAX Health Care
  • IMCC Health Care
  • Exchange
  • EVAX Nasdaq
  • IMCC Nasdaq
  • Market Cap
  • EVAX 8.7M
  • IMCC 7.5M
  • IPO Year
  • EVAX 2021
  • IMCC N/A
  • Fundamental
  • Price
  • EVAX $2.62
  • IMCC $2.37
  • Analyst Decision
  • EVAX Strong Buy
  • IMCC
  • Analyst Count
  • EVAX 3
  • IMCC 0
  • Target Price
  • EVAX $33.33
  • IMCC N/A
  • AVG Volume (30 Days)
  • EVAX 6.9M
  • IMCC 16.9K
  • Earning Date
  • EVAX 03-26-2025
  • IMCC 03-27-2025
  • Dividend Yield
  • EVAX N/A
  • IMCC N/A
  • EPS Growth
  • EVAX N/A
  • IMCC N/A
  • EPS
  • EVAX N/A
  • IMCC N/A
  • Revenue
  • EVAX $3,295,000.00
  • IMCC $38,042,859.00
  • Revenue This Year
  • EVAX $4,845.21
  • IMCC $22.59
  • Revenue Next Year
  • EVAX $30.30
  • IMCC $32.86
  • P/E Ratio
  • EVAX N/A
  • IMCC N/A
  • Revenue Growth
  • EVAX N/A
  • IMCC N/A
  • 52 Week Low
  • EVAX $2.22
  • IMCC $1.41
  • 52 Week High
  • EVAX $23.70
  • IMCC $8.10
  • Technical
  • Relative Strength Index (RSI)
  • EVAX 41.09
  • IMCC 53.35
  • Support Level
  • EVAX $2.22
  • IMCC $2.05
  • Resistance Level
  • EVAX $4.05
  • IMCC $2.60
  • Average True Range (ATR)
  • EVAX 1.17
  • IMCC 0.21
  • MACD
  • EVAX 0.00
  • IMCC 0.02
  • Stochastic Oscillator
  • EVAX 6.99
  • IMCC 58.31

About EVAX Evaxion Biotech

Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.

About IMCC IM Cannabis Corp.

IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.

Share on Social Networks: